Skip to content
healthcare.dev

Neostigmine Methylsulfate

NDC 70069-805, Neostigmine Methylsulfate, injection, from Somerset Therapeutics, LLC.

Product NDC
70069-805
Status
Listed
Labeler
Somerset Therapeutics, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-805 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.5 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
70069-805-107006908051010 VIAL, MULTI-DOSE in 1 CARTON (70069-805-10) / 10 mL in 1 VIAL, MULTI-DOSE (70069-805-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea767851-b0ab-4a4c-a4b2-680ff4086636

Use it

Look up 70069-805 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-805 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.